 | | | | LOS ANGELES (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it. | | | | | | LONDON (Reuters) - The concept of combining two immunotherapy drugs to fight lung cancer - not so long ago one of the hottest ideas in cancer research - has suffered a fresh blow from the failure of an AstraZeneca clinical study. | | | | | | LONDON (Reuters) - A Sanofi drug for epilepsy and bipolar disorder linked to thousands of birth defects has been banned in Britain for use in women or girls of child-bearing age, unless they are on a special pregnancy prevention program. | | | | | | (Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias Zerhouni retires from the French drugmaker. | | | | | | (Reuters) - An arthritis drug developed by Eli Lilly & Co and Incyte Corp should not be approved at a 4-milligram dose, advisers to the U.S. FDA voted on Monday, in a setback to the drugmakers that were counting on the treatment as a future blockbuster. | | | | | | (Reuters) - A soldier wounded by an improvised explosive device in Afghanistan has received the world's first complete penis and scrotum transplant, officials at Johns Hopkins Hospital in Baltimore said on Monday. | | | | | | WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday. | | | | | | (Reuters Health) - Electromagnetic fields produced by motors in electric cars don't appear strong enough to interfere with implanted heart devices like pacemakers and defibrillators, a small German study suggests. | | | | | | (Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information. | | | | | | (Reuters Health) - Teens who use e-cigarettes may be twice as likely to smoke pot as their peers who never try vaping, a U.S. study suggests. | | | | | |
